Evidence map›Paper›PMID 20082153›Full record

ReviewImmunologic research2010

Controlling somatic hypermutation in immunoglobulin variable and switch regions.

Robert W Maul, Patricia J Gearhart

Open access · greenAbstract readReview
In one paragraph

Review in Immunologic research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Frontiers in oncology · 2019
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2014
    Article
  14. Article
  15. Base excision repair.Cold Spring Harbor perspectives in biology · 2013
    Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Robert W MaulLaboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
Patricia J Gearhart
National Institutes of Health · US

Funding

Protein Interactions in Antibody DiversityZIAAG000732 · NIA · NATIONAL INSTITUTE ON AGING · PI GEARHART, PATRICIA J · 2009 to 2025
$10.7M
Protein Interactions in Antibody DiversityZ01AG000732 · NIA · NATIONAL INSTITUTE ON AGING · PI GEARHART, PATRICIA J · 1996 to 2008
$974k
Intramural NIH HHS Z01 AG000732
6 · The paper itself

Abstract

Activation-induced deaminase (AID) is a B-cell-specific enzyme required for initiating the mechanisms of affinity maturation and isotype switching of antibodies. AID functions by deaminating cytosine to uracil in DNA, which initiates a cascade of events resulting in mutations and strand breaks in the immunoglobulin loci. There is an intricate interplay between faithful DNA repair and mutagenic DNA repair during somatic hypermutation, in that some proteins from accurate repair pathways are also involved in mutagenesis. One factor that shifts the balance from faithful to mutagenic repair is the genomic sequence of the switch regions. Indeed, the sequence of the switch mu region is designed to maximize AID access to increase the abundance of clustered dU bases. The frequency and proximity of these dU nucleotides then in turn inhibit faithful repair and promote strand breaks.

Indexed as

Immunoglobulin Class SwitchingMutationSomatic Hypermutation, ImmunoglobulinAICDA (Activation-Induced Cytidine Deaminase)AnimalsBase SequenceCytidine DeaminaseDNA RepairHumansImmunoglobulinsImmunoglobulin Switch RegionImmunoglobulin Variable RegionMiceUracil-DNA GlycosidaseAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseImmunoglobulinsImmunoglobulin Variable RegionUracil-DNA Glycosidase

Identifiers

PMID20082153
PMCPMC2952935
OpenAlexW1982450600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.